Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 4-[4-(2-Methoxyphenyl)piperazin-1-yl]-1-(4-methylphenyl)-1H-pyrazolo[3,4-d]pyrimidine | IC50 | 3000.0 [1] | |
| 1-Cyclopentyl-4-[4-(2-methoxyphenyl)piperazin-1-yl]pyrazolo[3,4-d]pyrimidine | IC50 | 120.0 [1] | |
| 1-(5-Fluoro-2-methoxyphenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]pyrazolo[3,4-d]pyrimidine | IC50 | 320.0 [1] | |
| 1-(3,5-Difluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]pyrazolo[3,4-d]pyrimidine | IC50 | 90.0 [1] | |
| 6-[4-(2-Methoxyphenyl)piperazin-1-yl]-9-phenylpurine | IC50 | 64.0 [1] | |
MLA | "Quest Database™ Solute carrier family 2, facilitated glucose transporter member 3 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 13 Dec. 2025, https://www.aatbio.com/data-sets/solute-carrier-family-2-facilitated-glucose-transporter-member-3-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 13). Quest Database™ Solute carrier family 2, facilitated glucose transporter member 3 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/solute-carrier-family-2-facilitated-glucose-transporter-member-3-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |